STUDY DESIGN: We investigated the mechanism of discogenic low back pain using an in vitro model. OBJECTIVE: To evaluate the axonal growth and induction of a painful neuropeptide, substance P (SP), using rat dorsal root ganglion (DRG) neurons and degenerated human disc cells in vitro. SUMMARY OF BACKGROUND DATA: Degeneration of the lumbar intervertebral disc is a cause of low back pain. The pathologic mechanism is thought to be sensory nerve ingrowth into the inner layers of the degenerated intervertebral disc; however, the precise patho-mechanism has not been clarified. METHODS: The nucleus pulposus (NP) and annulus fibrosus (AF) of human intervertebral discs were harvested from patients with discogenic low back pain. Extracted medium from human degenerative intervertebral discs was cultured with neurons of rat DRGs. We evaluated the promotion of axonal growth and SP induction of DRG neurons in extracted medium from the NP and AF using immunocytochemistry. RESULTS: The average length of growing axons in the NP and AF was significantly longer than that in the control (P < 0.005). That in the NP was significantly longer than that in the AF. The average length of growing axons in the NP was significantly shortened after anti-nerve growth factor (NGF)beta treatment (P < 0.005); however, that in the AF was not (P > 0.05). The percentage of SP-immunoreactive cells with growing axons was significantly higher only in the NP group compared with the control and AF groups (P < 0.005), and anti-NGFbeta treatment decreased the expression of SP in the NP group (P < 0.05). CONCLUSION: Extracted medium from the NP and AF promoted axonal growth. Furthermore, NGF from the NP promoted axonal growth and induced SP. These in vitro results may suggest that NGF from the NP promotes the growth of sensory nerve fibers innervating the degenerated intervertebral disc and may induce SP related with pain transmission.
STUDY DESIGN: We investigated the mechanism of discogenic low back pain using an in vitro model. OBJECTIVE: To evaluate the axonal growth and induction of a painful neuropeptide, substance P (SP), using rat dorsal root ganglion (DRG) neurons and degenerated human disc cells in vitro. SUMMARY OF BACKGROUND DATA: Degeneration of the lumbar intervertebral disc is a cause of low back pain. The pathologic mechanism is thought to be sensory nerve ingrowth into the inner layers of the degenerated intervertebral disc; however, the precise patho-mechanism has not been clarified. METHODS: The nucleus pulposus (NP) and annulus fibrosus (AF) of human intervertebral discs were harvested from patients with discogenic low back pain. Extracted medium from human degenerative intervertebral discs was cultured with neurons of rat DRGs. We evaluated the promotion of axonal growth and SP induction of DRG neurons in extracted medium from the NP and AF using immunocytochemistry. RESULTS: The average length of growing axons in the NP and AF was significantly longer than that in the control (P < 0.005). That in the NP was significantly longer than that in the AF. The average length of growing axons in the NP was significantly shortened after anti-nerve growth factor (NGF)beta treatment (P < 0.005); however, that in the AF was not (P > 0.05). The percentage of SP-immunoreactive cells with growing axons was significantly higher only in the NP group compared with the control and AF groups (P < 0.005), and anti-NGFbeta treatment decreased the expression of SP in the NP group (P < 0.05). CONCLUSION: Extracted medium from the NP and AF promoted axonal growth. Furthermore, NGF from the NP promoted axonal growth and induced SP. These in vitro results may suggest that NGF from the NP promotes the growth of sensory nerve fibers innervating the degenerated intervertebral disc and may induce SP related with pain transmission.
Authors: José García-Cosamalón; Miguel E del Valle; Marta G Calavia; Olivia García-Suárez; Alfonso López-Muñiz; Jesús Otero; José A Vega Journal: J Anat Date: 2010-04-26 Impact factor: 2.610
Authors: Sonia Kartha; Martha E Zeeman; Hassam A Baig; Benjamin B Guarino; Beth A Winkelstein Journal: Spine (Phila Pa 1976) Date: 2014-09-01 Impact factor: 3.468
Authors: Jan L Bjersing; Mats Dehlin; Malin Erlandsson; Maria I Bokarewa; Kaisa Mannerkorpi Journal: Arthritis Res Ther Date: 2012-07-09 Impact factor: 5.156
Authors: Emerson Krock; Derek H Rosenzweig; Anne-Julie Chabot-Doré; Peter Jarzem; Michael H Weber; Jean A Ouellet; Laura S Stone; Lisbet Haglund Journal: J Cell Mol Med Date: 2014-03-20 Impact factor: 5.310
Authors: Stephen M Richardson; Devina Purmessur; Pauline Baird; Ben Probyn; Anthony J Freemont; Judith A Hoyland Journal: PLoS One Date: 2012-10-16 Impact factor: 3.240